Brief: Adamis Pharmaceuticals Gets Notice Of Not Satisfy Certain Requirement From Nasdaq
30/12/2022 21:57
Dec 30 (Reuters) - Adamis Pharmaceuticals Corp ADMP.O :
* ADAMIS PHARMACEUTICALS CORP - ON DECEMBER 28, GOT NOTICE
FROM
NASDAQ NOTIFYING THAT CO DID NOT SATISFY CERTAIN CONTINUED
LISTING REQUIREMENT
Source: (https://bit.ly/3Wz2Xsl)
Further company coverage: ADMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update